← All trials
NCT03616288
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2018
- Primary completion
- Sep 30, 2019
- Completion date
- Aug 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 320
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Mount Saint Vincent UniversityLead sponsor
- Government of FranceCollaborator
- Bill and Melinda Gates FoundationCollaborator
- University of OregonCollaborator
- Helen Keller InternationalCollaborator
- Government of CambodiaCollaborator
- Mount Saint Vincent UniversityReponsible party - principal investigator
- Mount Saint Vincent UniversityOverall official - principal investigator
- The New York Academy of MedicineCollaborator
- South Australian Health and Medical Research InstituteCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.